In this issue:
8- vs 16-week prednisolone course for childhood nephrotic syndrome
Renal effects of canagliflozin in type 2 diabetics with CKD
Hydroxychloroquine in patients with IgA nephropathy
Screening for colorectal cancer in patients with CKD
Magnesium oxide slows CAC in predialysis CKD
Nicotinamide and lanthanum fail to reduce phosphate or FGF23 levels in CKD
Cost-effectiveness of statins and ezetimibe in CKD
Dual antiplatelet therapy in CKD patients with drug-eluting stents
Glomerular hyperfiltration in type 1 diabetics
Renal effects of everolimus in patients with tuberous sclerosis complex
Please login below to download this issue (PDF)